Clinical Trial Update: Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aprepitant plus granisetron and dexamethasone for preventing vomiting in patients undergoing hepatic arterial infusion chemotherapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Granisetron (granisetron)

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN